Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares traded up 14.7% during mid-day trading on Thursday . The stock traded as high as GBX 44.85 ($0.59) and last traded at GBX 43 ($0.57). 252,993 shares were traded during mid-day trading, an increase of 337% from the average session volume of 57,927 shares. The stock had previously closed at GBX 37.50 ($0.49).
Celadon Pharmaceuticals Stock Up 33.3 %
The stock has a market capitalization of £33.11 million, a price-to-earnings ratio of -416.67 and a beta of -0.25. The firm’s fifty day moving average is GBX 51.21 and its 200-day moving average is GBX 79.77. The company has a debt-to-equity ratio of 148.29, a current ratio of 2.62 and a quick ratio of 6.97.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- How to Use the MarketBeat Stock Screener
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- What is Insider Trading? What You Can Learn from Insider Trading
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
